• Corticotropin Releasing Hormone (CRH)
  • Porphyrins, Quantitative, Random, Urine
  • Vancomycin, Trough, Serum
  • Immunohistochemistry for Burkitt lymphoma panel CD20, CD10, BCL-6, BCL-2, Ki-67.
  • HIV Co-Receptor Tropism (Trofile) Assay
  • Methlyenetetrahydrofolate reductase (MTHFR) Mutation Analysis
  • Dexamethasone Suppression Test (High Dose)
  • Enterocyte Ab Panel (IgA, IgG, IgM), Serum
  • D-Lactate, Plasma
  • Synovial Sarcoma (SS), 18q11.2 (SS18 or SYT) Rearrangement, FISH, Tissue
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Hereditary Neuroendocrine Tumor Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Hereditary Neuroendocrine Tumor Gene Mutation Panel, NGS
Medical Test

Turnaround Time
Access to Hereditary Neuroendocrine Tumor Gene Mutation Panel, NGS is restricted.